Aug 20, 2012
BNDES posts profit of R$ 2.7 billion in the first half
The BNDES posted a net income of R$ 2.7 billion in the first half of 2012. In a period marked by the instability of financial markets and the weak performance of the stock markets, the fixed income segment was the main factor that contributed to the result.
Jul 26, 2012
BNDES provides R$ 28.9 million in support to innovative pharmaceutical firm
The BNDES has approved financial support for Recepta Biopharma S.A. in the amount of R$ 28.9 million. The company employs biotechnology to produce pharmaceutical products used in treating cancer, a high-tech sector with the potential to generate benefits for society as a whole. BNDESPAR, the BNDES’ corporate shareholding arm, will subscribe the company’s shares, holding a part of its capital.